PD-1 drugs for Melanoma
5 tracked PD-1 drugs in the Melanoma race. The class explanation lives on the PD-1 page; the full indication pipeline across every mechanism is on the Melanoma page.
4 approved / phase 41 Phase 3
Head-to-head evidence: Cemiplimab vs Nivolumab · Cemiplimab vs Pembrolizumab · Cemiplimab vs Pembrolizumab berahyaluronidase alfa · Nivolumab vs Opdivo Qvantig · Nivolumab vs Pembrolizumab · Nivolumab vs Pembrolizumab berahyaluronidase alfa